Bristol-Myers Squibb
BMY
#176
Rank
A$184.36 B
Marketcap
A$90.19
Share price
-1.66%
Change (1 day)
24.72%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$6.55

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$6.60. In 2025 the company made an earnings per share (EPS) of A$5.05 an increase over its 2024 EPS that were of A-$6.45.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$6.5529.7%
2025A$5.05-178.28%
2024A-$6.45-213.92%
2023A$5.6730.2%
2022A$4.35-6.04%
2021A$4.63-179.29%
2020A-$5.84-281.37%
2019A$3.22-27.21%
2018A$4.43
2016A$3.90175.26%
2015A$1.42-19.83%
2014A$1.77-22.44%
2013A$2.2834.48%
2012A$1.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.76 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.67 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.04-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.55 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.11 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.38 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.89-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$3.45-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.45-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.40 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK